FDA May Reverse Ban on 14 PeptidesWhat It Means for Your Beauty Routine Allure When will the FDA reclassify BPC 157 to Category 1? Odds & Predictions In a major policy shift, the U.S. Food and Drug Administration is reconsidering restrictions on several controversial peptides, including trending compounds like BPC 157 and Melanotan II. The move comes as demand for FDA has removed certain bulk drug substances that were placed on the category two list and has announced it will consult the Pharmacy Compounding Advisory Committee (PCAC) for potential future inclusion of